- Home
- NVAX vs GSL Comparison
NVAX vs GSL Comparison
Compare NVAX & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- GSL
- Stock Information
- Founded
- NVAX 1987
- GSL 2007
- Country
- NVAX United States
- GSL Greece
- Employees
- NVAX N/A
- GSL N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- GSL Marine Transportation
- Sector
- NVAX Health Care
- GSL Consumer Discretionary
- Exchange
- NVAX Nasdaq
- GSL Nasdaq
- Market Cap
- NVAX 1.3B
- GSL 1.1B
- IPO Year
- NVAX 1995
- GSL 2006
- Fundamental
- Price
- NVAX $8.64
- GSL $32.07
- Analyst Decision
- NVAX Buy
- GSL Strong Buy
- Analyst Count
- NVAX 7
- GSL 1
- Target Price
- NVAX $14.29
- GSL $33.00
- AVG Volume (30 Days)
- NVAX 6.9M
- GSL 320.2K
- Earning Date
- NVAX 11-11-2025
- GSL 11-10-2025
- Dividend Yield
- NVAX N/A
- GSL 6.45%
- EPS Growth
- NVAX N/A
- GSL 19.05
- EPS
- NVAX 2.54
- GSL 10.76
- Revenue
- NVAX $1,078,718,000.00
- GSL $730,277,000.00
- Revenue This Year
- NVAX $61.69
- GSL $5.44
- Revenue Next Year
- NVAX N/A
- GSL N/A
- P/E Ratio
- NVAX $3.18
- GSL $2.97
- Revenue Growth
- NVAX 9.22
- GSL 4.04
- 52 Week Low
- NVAX $5.01
- GSL $17.73
- 52 Week High
- NVAX $15.22
- GSL $33.05
- Technical
- Relative Strength Index (RSI)
- NVAX 60.46
- GSL 52.94
- Support Level
- NVAX $7.83
- GSL N/A
- Resistance Level
- NVAX $8.31
- GSL $32.45
- Average True Range (ATR)
- NVAX 0.37
- GSL 0.49
- MACD
- NVAX 0.05
- GSL -1.09
- Stochastic Oscillator
- NVAX 99.49
- GSL 98.28
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.